Nearly every one of the top cannabis stocks have outperformed ACB. CGC, Cronos, Aphria, etc. Tilray maybe being the only exception since it has settled at around $71 pps from a ridiculous $225+ high. I personally think even at $71 pps its a house of cards. Cronos is incredibly overbought on the Altria investment and realistically should be sitting at about a $14 pps. ACB has sucked tail pipe for some time now...it would be great to see sustained performance in line with its potential.
Market Data 
Markets 
